Unknown PHASE3 INTERVENTIONAL 2-arm NCT03578055

BDD With UDCA Therapy After Laparoscopic Cholecystectomy (BULQ-LC)

Prospective Study for the Effects of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycolic Acid Therapy on Liver Function and Quality of Life After Laparoscopic Cholecystectomy

Sponsor: Ewha Womans University Mokdong Hospital

Conditions Cholecystitis, Acute Cholecystitis, Chronic

Interventions BDD with UDCA Placebo

Updated 6 times since 2018 Last updated: Jul 16, 2018 Started: Apr 24, 2018 Primary completion: Nov 30, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cholecystitis, Acute and Cholecystitis, Chronic and is currently ongoing. Ewha Womans University Mokdong Hospital leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Aug 2020 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Aug 2018 — Aug 2020 [monthly]

Recruiting PHASE3

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ewha Womans University Mokdong Hospital

Data source: Ewha Womans University Mokdong Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea